Amanta Healthcare Limited has submitted a regulatory disclosure to the BSE and NSE regarding trading activities by a member of its promoter group. The filing is made under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015.
The disclosure consists of a Form C received from Shri Kirit Ambalal Desai, identified as a member of the promoter group of the company.
Transaction Details
- Security Traded: Equity Shares of Amanta Healthcare Limited (ISIN: INE084K01015)
- Nature of Transaction: Sale
- Date of Transaction: June 15, 2026
- Number of Shares Sold: 5,000
- Value of Transaction: ₹7,86,550 (excluding taxes, brokerage, and other charges)
- Holding Change: The transaction resulted in a reduction of the promoter's holding from 11,33,079 shares (2.92%) to 11,28,079 shares (2.91%).
Derivatives Trading
The form includes a section for details of trading in derivatives on the company's securities. For all relevant fields in this section—including type of contract, contract specifications, buy/sell details, number of units, notional value, and exchange—the entry is marked as 'NA' (Not Applicable). A note clarifies that for Options, the notional value should be calculated based on the premium plus the strike price.
Declaration and Submission
The Form C was signed by Kirit Ambalal Desai in Ahmedabad on June 17, 2026. The company's letter to the exchanges was digitally signed by Nikhita Dinodia, Company Secretary & Compliance Officer, on the same date. The purpose of the submission is to comply with the continual disclosure requirements stipulated under Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015.